This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about G patch domain-containing protein 3.
Is a negative regulator of immune antiviral response, acting via down-regulation of RIG-I-like receptors signaling and inhibition of type I interferon production. The control mechanism involves interaction with mitochondrial MAVS and inhibition of MAVS meeting with downstream proteins implicated in antiviral response, such as TBK1 and TRAF6 (PubMed:28414768).
Human | |
---|---|
Gene Name: | GPATCH3 |
Uniprot: | Q96I76 |
Entrez: | 63906 |
Belongs to: |
---|
No superfamily |
DKFZp686E0221; FLJ12455; G patch domain containing 3; G patch domain-containing protein 3; GPATC3
Mass (kDA):
59.338 kDA
Human | |
---|---|
Location: | 1p36.11 |
Sequence: | 1; NC_000001.11 (26890488..26900467, complement) |
Expressed in ocular tissues including retinal pigment epithelium, cornea, ciliary muscle and non-pigmented ciliary epithelium. Also expressed in optic nerve, cartilage, skin and lymph node.
Nucleus. Cytoplasm.
PMID: 28414768 by Nie Y., et al. GPATCH3 negatively regulates RLR-mediated innate antiviral responses by disrupting the assembly of VISA signalosome.
PMID: 28397860 by Ferre-Fernandez J.J., et al. Whole-exome sequencing of congenital glaucoma patients reveals hypermorphic variants in GPATCH3, a new gene involved in ocular and craniofacial development.